|
|
Sold Out
Book Categories |
| Preface | ||
| Contributors | ||
| Pt. I | Basic Principles | |
| 1 | Thrombosis in Acute Coronary Syndromes and Coronary Interventions | 3 |
| 2 | Platelet Adhesion | 23 |
| 3 | Glycoprotein IIb/IIIa in Platelet Aggregation and Acute Arterial Thrombosis | 39 |
| 4 | Glycoprotein IIb/IIIa Antagonists: Development of Abciximab and Pharmacology of Abciximab, Tirofiban, and Eptifibatide | 73 |
| Pt. II | Glycoprotein IIb/IIIa Blockade During Coronary Intervention | |
| 5 | Abeiximab During Percutaneous Coronary Intervention: EPIC, EPILOG, and EPISTENT Trials | 105 |
| 6 | Eptifibatide in Coronary Intervention: The IMPACT and ESPRIT Trials | 125 |
| 7 | Tirofiban in Interventional Cardiology: The RESTORE and TARGET Trials | 147 |
| 8 | Overview of the Glycoprotein IIb/IIIa Interventional Trials | 167 |
| Pt. III | Glycoprotein IIb/IIIa Blockade for Acute Ischemic Syndromes | |
| 9 | The Use of Abciximab in Therapy-Resistant Unstable Angina: Clinical and Angiographic Results of the CAPTURE Pilot Trial and the CAPTURE Study | 203 |
| 10 | Unstable Angina Trials: PARAGON, PURSUIT, PRISM, PRISM-PLUS, and GUSTO-IV | 233 |
| 11 | Platelet Glycoprotein IIb/IIIa Inhibitors and an Invasive Strategy | 263 |
| 12 | Glycoprotein IIb/IIIa Receptor Blockade in Myocardial Infarction: Adjunctive Therapy to Percutaneous Coronary Interventions | 275 |
| 13 | Glycoprotein IIb/IIIa Receptor Blockade in Acute Myocardial Infarction: Adjunctive Therapy to Fibrinolysis | 289 |
| Pt. IV | Practical Issues and Future Applications | |
| 14 | Economics of Glycoprotein IIb/IIIa Inhibition | 305 |
| 15 | Platelet Monitoring and Interaction of Glycoprotein IIb/IIIa Antagonists with Other Antiplatelet Agents | 321 |
| 16 | Platelet Glycoprotein IIb/IIa Antagonists: Their Interaction with Low-Molecular-Weight Heparins and Direct Thrombin Inhibitors | 341 |
| 17 | Oral Agents | 365 |
| 18 | Platelet Glycoprotein IIb/IIIa Inhibitors: Effects Beyond the Platelet | 383 |
| 19 | Cerebrovascular Interventions | 397 |
| 20 | Cerebrovascular Aspects of Glycoprotein IIb/IIIa Receptor Inhibitors | 409 |
| 21 | Evolution of Drug Development in Evidence-Based Medicine: Summary and the Future | 425 |
| Index | 459 |
| Price | Condition | Delivery | Seller | Action |
| $149.50 | Digital |
| WonderClub |
Terry Mort
reviewed Platelet Glycoprotein IIb/IIIa Inhibitors in Cardiovascular Disease on November 21, 2018
Platelet Glycoprotein IIb/IIIa Inhibitors in Cardiovascular Disease
4/16/15 2.5
Login|Complaints|Blog|Games|Digital Media|Souls|Obituary|Contact Us|FAQ
CAN'T FIND WHAT YOU'RE LOOKING FOR? CLICK HERE!!! X
You must be logged in to add to WishlistX
This item is in your Wish List
X
This item is in your Collection
Platelet Glycoprotein IIb/IIIa Inhibitors in Cardiovascular Disease
X
This Item is in Your Inventory
Platelet Glycoprotein IIb/IIIa Inhibitors in Cardiovascular Disease
X
You must be logged in to review the productsX
X
X
Add Platelet Glycoprotein IIb/IIIa Inhibitors in Cardiovascular Disease, , Platelet Glycoprotein IIb/IIIa Inhibitors in Cardiovascular Disease to the inventory that you are selling on WonderClubX
X
Add Platelet Glycoprotein IIb/IIIa Inhibitors in Cardiovascular Disease, , Platelet Glycoprotein IIb/IIIa Inhibitors in Cardiovascular Disease to your collection on WonderClub |